StockData
CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30

Cencora, Inc.

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$340.00−0.92 (-0.27%)

Close on Oct 19, 2026

Market cap
$65.94B
P/E (TTM)
25.2
Dividend yield
0.65%

Cencora, Inc. revenue by segment

By business segment

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016% of revenueYoY
U.S. Healthcare Solutions$290.98B$265.34B$234.76B$212.10B$202.46B–––––90.6%+9.7%
International Healthcare Solutions$30.37B$28.63B$27.42B$26.49B$11.53B$3.51B––––9.5%+6.1%
Pharmaceutical Distribution Services––––$198.15B$182.47B$172.81B$161.70B$147.45B$141.70B––
Other––––$15.97B$7.53B$6.87B$6.33B$5.75B$5.21B––
Global Commercialization Services–––––$3.31B$2.89B$2.54B$2.11B–––
MWI Animal Health–––––$4.22B$3.98B$3.79B$3.64B–––
Operating incomeFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016YoY
U.S. Healthcare Solutions$3.57B$2.93B$2.60B$2.46B$2.26B$2.02B––––+21.8%
International Healthcare Solutions$648.27M$713.38M$692.56M$706.46M$390.29M$184.38M––––-9.1%
Pharmaceutical Distribution Services––––$2.04B$1.81B$1.67B$1.63B$1.64B$1.70B–
Other––––$614.97M$400.14M$380.66M$355.09M$373.80M$327.75M–

By product or service

By region

From the segment and revenue-disaggregation notes of Cencora's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.